Your browser doesn't support javascript.
loading
The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.
Meier, Ruth; Greve, Gabriele; Zimmer, Dennis; Bresser, Helena; Berberich, Bettina; Langova, Ralitsa; Stomper, Julia; Rubarth, Anne; Feuerbach, Lars; Lipka, Daniel B; Hey, Joschka; Grüning, Björn; Brors, Benedikt; Duyster, Justus; Plass, Christoph; Becker, Heiko; Lübbert, Michael.
Afiliación
  • Meier R; Department of Medicine I (Hematology, Oncology and Stem Cell Transplantation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Greve G; Institute of Genetic Epidemiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Zimmer D; Department of Medicine I (Hematology, Oncology and Stem Cell Transplantation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Bresser H; Department of Medicine I (Hematology, Oncology and Stem Cell Transplantation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Berberich B; Department of Medicine I (Hematology, Oncology and Stem Cell Transplantation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Langova R; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stomper J; Faculty of Bioscience, University of Heidelberg, Heidelberg, Germany.
  • Rubarth A; Department of Medicine I (Hematology, Oncology and Stem Cell Transplantation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Feuerbach L; Department of Medicine I (Hematology, Oncology and Stem Cell Transplantation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Lipka DB; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hey J; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Grüning B; Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany.
  • Brors B; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
  • Duyster J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Plass C; Bioinformatics Group, Department of Computer Science, University of Freiburg, Freiburg, Germany.
  • Becker H; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lübbert M; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
Blood Cancer J ; 12(8): 122, 2022 08 22.
Article en En | MEDLINE | ID: mdl-35995769
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Alemania